Ardelyx ARDX Enterprise value

Enterprise value at other companies

AmgenAMGN

$252.17B+23.1%

Bausch Health CompaniesBHC

$21.45B-5.6%

Ironwood PharmaceuticalsIRWD

$625.76M+163%

AbbVieABBV

$460.96B+24.7%

Eton Pharmaceuticals, Inc.ETON

$684.98M+89.8%

XER

Xeris Biopharma Holdings, Inc.XERS

$1.54B+62.6%

FAQ

What is Ardelyx's enterprise value?

Ardelyx (ARDX) reported enterprise value of $1.42B in Q2 2026.

How has Ardelyx's enterprise value changed year-over-year?

Ardelyx's enterprise value increased by 42.3% year-over-year, from $997.06M to $1.42B.

What is the long-term trend for Ardelyx's enterprise value?

Over 5 years (2020 to 2025), Ardelyx's enterprise value has grown at a 19.4% compound annual growth rate (CAGR), from $640.95M to $1.56B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.